Quadrivalent Influenza Vaccine (split virion, inactivated)
Sponsors
Sanofi Pasteur, a Sanofi Company, Butantan Institute
Conditions
InfluenzaInfluenza, Human
Phase 3
Study of a Quadrivalent Influenza Vaccine Administered Intramuscularly in Children/Adolescents and Adults
CompletedNCT01481454
Start: 2012-03-31End: 2012-12-31Updated: 2013-03-29
Study of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in Taiwan
CompletedNCT01967784
Start: 2013-10-31End: 2014-07-31Updated: 2016-01-20
Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children .
CompletedNCT05779020
Start: 2023-04-25End: 2025-08-02Updated: 2025-09-19